生物活性 | |||
---|---|---|---|
描述 | SET2 is a specific TRPV2 antagonist with an IC50 of 0.46 μM. It inhibits the TRP channel and attenuates the migration of prostate cancer cells. Additionally, SET2 diminishes the elevation of cytoplasmic calcium induced by lysophosphatidic acid (LPA), an activator of TRPV2[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.48mL 0.50mL 0.25mL |
12.42mL 2.48mL 1.24mL |
24.85mL 4.97mL 2.48mL |
参考文献 |
---|